Log in to your Inderes Free account to see all free content on this page.
LIDDS
0.02 SEK
+13.33 %
Less than 1K followers
LIDDS
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+13.33 %
-61.36 %
-59.52 %
-71.57 %
-81.03 %
-86.77 %
-98.86 %
-99.87 %
-99.82 %
LIDDS is a pharmaceutical company. The company develops pharmaceutical products based on a patented and clinically tested drug delivery technology. The properties of the products form the basis of the LIDDS technology platform for the development of injectable pharmaceutical products. LIDDS is the abbreviation for Local Intelligent Drug Delivery System, and the company is headquartered in Uppsala.
Read moreMarket cap
2.32M SEK
Turnover
2.46K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
28.1.
2026
Extraordinary general meeting '26
19.2.
2026
Annual report '25
28.5.
2026
Interim report Q1'26
All
Press releases
ShowingAll content types
LIDDS AB (publ) proposes that the general meeting, as well as the second control meeting, resolve on voluntary liquidation and the delisting of the company’s shares
Announcement from extraordinary general meeting in LIDDS AB (publ) held on 18 December 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio